SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 2.83 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,000 | -20.0% | 17,000 | -22.7% | 0.00% | – |
| Q1 2016 | $5,000 | -37.5% | 22,000 | -0.5% | 0.00% | – |
| Q4 2015 | $8,000 | -77.1% | 22,100 | +10.5% | 0.00% | – |
| Q3 2015 | $35,000 | +6.1% | 20,000 | +33.3% | 0.00% | – |
| Q2 2015 | $33,000 | -32.7% | 15,000 | -40.0% | 0.00% | – |
| Q1 2015 | $49,000 | +22.5% | 25,000 | +66.7% | 0.00% | – |
| Q4 2014 | $40,000 | -13.0% | 15,000 | -2.0% | 0.00% | -100.0% |
| Q3 2014 | $46,000 | -35.2% | 15,300 | -11.6% | 0.00% | 0.0% |
| Q2 2014 | $71,000 | -2.7% | 17,300 | +1.8% | 0.00% | 0.0% |
| Q1 2014 | $73,000 | -20.7% | 17,000 | -3.4% | 0.00% | -50.0% |
| Q4 2013 | $92,000 | +607.7% | 17,600 | +780.0% | 0.00% | – |
| Q3 2013 | $13,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 23,634,349 | $149,133,000 | 99.87% |
| Perceptive Advisors | 4,762,472 | $30,052,000 | 1.24% |
| QVT Financial LP | 1,750,285 | $11,044,000 | 0.75% |
| NBW CAPITAL LLC | 404,721 | $2,554,000 | 0.45% |
| Tekla Capital Management LLC | 489,750 | $3,090,000 | 0.34% |
| MILES CAPITAL, INC. | 57,904 | $365,000 | 0.21% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 435,200 | $2,746,000 | 0.16% |
| Old West Investment Management, LLC | 49,136 | $310,000 | 0.15% |
| Integre Asset Management, LLC | 84,420 | $533,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 250,952 | $1,584,000 | 0.10% |